Stock Events

Stock Events

Personalis 

€14.04
0
-€0.01-0.07%Friday 16:30

Statistics

Day High
14.05
Day Low
13.9
52W High
14.38
52W Low
13.9
Volume
-
Avg. Volume
-
Mkt Cap
1.5B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 4Expected
Q2 2026
Q3 2026
-0.28
-0.27
-0.25
-0.23
Expected EPS
-0.23438743663999997
Actual EPS
-0.2848256

Financials

-115.7%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
60.77MRevenue
-70.31MNet Income

Analyst Ratings

$11.10Average Price Target
The highest estimate is ⁦12.33⁩.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 04X.XETRA. It's not an investment recommendation.
NVIDIA
14
NVDA
Microsoft
11
MSFT
Apple
10
AAPL
Realty Income
10
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides sequencing and array-based solutions for genetic and genomic analysis, competing directly in the genomics space with Personalis.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers long-read sequencing technologies, which compete with Personalis in the comprehensive genomic analysis market.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with Personalis in the genomic cancer testing market.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Personalis in the space of genomic profiling and analysis.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomics and diagnostics market alongside Personalis.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics provides tools for genomic analysis, including optical genome mapping solutions that compete with Personalis' genomic services.
Twist Bioscience
TWST
Mkt Cap10.13B
Twist Bioscience operates in the synthetic biology and genomics fields, offering products that compete with Personalis in the genomic research and clinical markets.
Adaptive Biotechnologies
ADPT
Mkt Cap4.25B
Adaptive Biotechnologies focuses on the immune-driven medicine space, offering genomic testing services that compete with Personalis in the personalized medicine and diagnostics field.

About

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Show More
CEO
Christopher Hall
Employees
260
Country
United States
ISIN
US71535D1063
WKN
000A2PLTK

Listings

F
DE
04X.F
STU
DE
04X.STU
MU
DE
04X.MU
XNAS
US
PSNL

0 Comments

Share your thoughts

FAQs

What is Personalis stock price today?▼
The current price of 04X.XETRA is €14.04 EUR — it has decreased by -0.07% in the past 24 hours. Watch Personalis stock price performance more closely on the chart.
What is Personalis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Personalis stocks are traded under the ticker 04X.XETRA.
What is Personalis market cap?▼
Today Personalis has the market capitalization of 1.5B
When is the next Personalis earnings date?▼
Personalis is going to release the next earnings report on February 25, 2027.
What were Personalis earnings last quarter?▼
04X.XETRA earnings for the last quarter are -0.28 EUR per share, whereas the estimation was -0.23 EUR resulting in a -21.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Personalis revenue for the last year?▼
Personalis revenue for the last year amounts to 60.77M EUR.
What is Personalis net income for the last year?▼
04X.XETRA net income for the last year is -70.31M EUR.
How many employees does Personalis have?▼
As of November 8, 2026, the company has 260 employees.
In which sector is Personalis located?▼
Personalis operates in the Health & Wellness sector.
When did Personalis complete a stock split?▼
Personalis has not had any recent stock splits.
Where is Personalis headquartered?▼
Personalis is headquartered in FREMONT, United States.